Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma

Stopped Closed short of the enrollment goal, due to slow enrollment and adequate data to address endpoints

Conditions

• Melanoma

Interventions

• BIOLOGICAL: A combination of intratumoral IFN-gamma plus systemic vaccination with MELITAC 12.1

Sponsor

Craig L Slingluff, Jr